1
|
Hamzah H, Nuryastuti T, Rahmah W, Chabib L, Syamsul ES, Lestari D, Jabbar A, Tunjung Pratiwi SU. Molecular Docking Study of the C-10 Massoia Lactone Compound as an Antimicrobial and Antibiofilm Agent against Candida tropicalis. ScientificWorldJournal 2023; 2023:6697124. [PMID: 37766863 PMCID: PMC10522437 DOI: 10.1155/2023/6697124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 08/14/2023] [Accepted: 08/26/2023] [Indexed: 09/29/2023] Open
Abstract
Antimicrobial resistance is now considered a global health problem because it reduces the effectiveness of antimicrobial drugs. According to the World Health Organization (WHO), the highest mortality rate is associated with infections caused by multidrug-resistant microorganisms, with approximately 700,000 deaths worldwide each year. The aim of this study was to determine the potential of C-10 massoia lactone to inhibit the growth of fungi and C. tropicalis biofilm, and molecular docking studies were performed to determine the nature of the inhibition. The study was conducted using the microdilution method for antifungal and antibiofilm testing and designed with a molecular docking approach. Furthermore, an analysis using the scanning electron microscope (SEM) was performed to evaluate the mechanism of effect. The results obtained showed that C-10 massoia lactone can inhibit the growth of fungi by 84.21% w/v. Meanwhile, the growth of C. tropicalis biofilm in the intermediate phase was 80.23% w/v and in the mature phase was 74.23% w/v. SEM results showed that C-10 massoia lactone damaged the EPS matrix of C. tropicalis so that hyphal formation was hindered due to damage to fungal cells, resulting in a decrease in attachment, density, and lysis of C. tropicalis fungal cells. Based on molecular docking tests, C-10 massoia lactone was able to inhibit biofilm formation without affecting microbial growth, while docking C-10 massoia lactone showed a significant binding and has the potential as an antifungal agent. In conclusion, the C-10 massoia lactone compound has the potential as an antibiofilm against C. tropicalis, so it can become a new antibiofilm agent.
Collapse
Affiliation(s)
- Hasyrul Hamzah
- Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
- Faculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, Kalimantan Timur 75124, Indonesia
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
| | - Titik Nuryastuti
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Department of Microbiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Farmako Street, North Sekip, Yogyakarta 55281, Indonesia
| | - Widya Rahmah
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Department of Microbiology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Farmako Street, North Sekip, Yogyakarta 55281, Indonesia
| | - Lutfi Chabib
- Department of Pharmacy, Islamic University of Indonesia, Yogyakarta, Indonesia
| | - Eka Siswanto Syamsul
- Department of Pharmacy, Sekolah Tinggi Ilmu Kesehatan Samarinda, Samarinda, East Borneo, Indonesia
| | - Dwi Lestari
- Faculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, Kalimantan Timur 75124, Indonesia
| | - Asriullah Jabbar
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Department of Pharmacy, Faculty of Pharmacy, Haluoleo University, Kendari 93232, Indonesia
| | - Sylvia Utami Tunjung Pratiwi
- Indonesian Biofilm Research Collaboration Centre (IBRCC), Farmako Street, Sekip Utara, Yogyakarta 55281, Indonesia
- Faculty of Pharmacy, Universitas Gadjah Mada, North Sekip, Yogyakarta 55281, Indonesia
| |
Collapse
|
2
|
Lee Y, Park SJ, Kim K, Kim TO, Lee SE. Antifungal and Antiaflatoxigenic Activities of Massoia Essential Oil and C10 Massoia Lactone against Aflatoxin-Producing Aspergillus flavus. Toxins (Basel) 2023; 15:571. [PMID: 37755997 PMCID: PMC10537029 DOI: 10.3390/toxins15090571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 09/07/2023] [Accepted: 09/15/2023] [Indexed: 09/28/2023] Open
Abstract
Fungal infection and mycotoxin contamination are major hazards to the safe storage and distribution of foods and feeds consumed by humans and livestock. This study investigated the antifungal and antiaflatoxigenic activities of massoia essential oil (MEO) and its major constituent, C10 massoia lactone (C10), against aflatoxin B (AFB)-producing Aspergillus flavus ATCC 22546. Their antifungal activities were evaluated using a disc diffusion assay, agar dilution method, and a mycelial growth inhibition assay with the AFB analysis using liquid chromatography triple quadrupole mass spectrometry. MEO and C10 exhibited similar antifungal and antiaflatoxigenic activities against A. flavus. C10 was a primary constituent in MEO and represented up to 45.1% of total peak areas analyzed by gas chromatography-mass spectrometry, indicating that C10 is a major compound contributing to the antifungal and antiaflatoxigenic activities of MEO. Interestingly, these two materials increased AFB production in A. flavus by upregulating the expression of most genes related to AFB biosynthesis by 3- to 60-fold. Overall, MEO and C10 could be suitable candidates as natural preservatives to control fungal infection and mycotoxin contamination in foods and feeds as Generally Recognized As Safe (GRAS) in the Flavor and Extract Manufacturers Association of the United States (FEMA), and MEO is a more suitable substance than C10 because of its wider range of uses and higher allowed concentration than C10.
Collapse
Affiliation(s)
- Yubin Lee
- Department of Integrative Biology, Kyungpook National University, Daegu 41566, Republic of Korea;
| | - Soo Jean Park
- Applied BioSciences, Macquarie University, North Ryde, NSW 2109, Australia;
| | - Kyeongnam Kim
- Institute of Quality and Safety Evaluation of Agricultural Products, Kyungpook National University, Daegu 41566, Republic of Korea;
| | - Tae-Oh Kim
- Department of Environmental Engineering, Kumoh National Institute of Technology, Gumi 39177, Republic of Korea
| | - Sung-Eun Lee
- Department of Integrative Biology, Kyungpook National University, Daegu 41566, Republic of Korea;
- Institute of Quality and Safety Evaluation of Agricultural Products, Kyungpook National University, Daegu 41566, Republic of Korea;
- Department of Applied Biosciences, Kyungpook National University, Daegu 41566, Republic of Korea
| |
Collapse
|
3
|
Ma J, Yang YC, Su LQ, Qin DM, Yuan K, Zhang Y, Wang RR. The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mouse. Lett Appl Microbiol 2021; 74:564-576. [PMID: 34958703 DOI: 10.1111/lam.13641] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Revised: 12/18/2021] [Accepted: 12/21/2021] [Indexed: 11/27/2022]
Abstract
Vulvovaginal candidiasis (VVC) is an infectious disease caused mainly by Candida albicans. Kangfuxin (KFX) is a traditional Chinese medicine preparation made from Periplaneta Americana extracts, which has the functions of promoting wound healing and enhancing body immunity and acting as an antifungal. Here, we evaluated the effect of KFX in VVC treatment in vitro and in vivo. The Minimum inhibitory concentration (MIC50 ) of KFX against C. albicans ranged from 7.65% to 20.57%. In addition, KFX was better than fluconazole (FLC) in inhibiting drug resistant C. albicans, and the effect was more obvious after 8h. KFX treatment also exhibited good activity in vivo. It restored the body weight and reduced the vulvovaginal symptoms in mice induced with VVC. It down-regulated the expression of the hyphae-related gene HWP1, thus inhibiting the growth and development of C. albicans hyphae. It also increased the number of neutrophils and promoted the scretion of Interleukin-17A (IL-17A), however decreased Interleukin-8 (IL-8) and Interleukin-1β (IL-1β) in mice with VVC. We deduce that KFX effectively treats vaginal candidiasis in two ways: inhibiting the growth and development of mycelia to reduce C. albicans colonization and promoting the release of IL-17A and neutrophils number to fight C. albicans infection. This study provides a theoretical basis for the use of KFX for the clinical treatment of VVC.
Collapse
Affiliation(s)
- Jia Ma
- College of pharmacy, Dali University, Dali, 671000, China
| | - Ya-Chao Yang
- College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, China
| | - Liu-Qing Su
- College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, China
| | - Ding-Mei Qin
- College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, China
| | - Kai Yuan
- The Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, 650500, China
| | - Yi Zhang
- College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, China
| | - Rui-Rui Wang
- College of pharmacy, Dali University, Dali, 671000, China.,College of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650500, China
| |
Collapse
|
4
|
Peterfalvi A, Miko E, Nagy T, Reger B, Simon D, Miseta A, Czéh B, Szereday L. Much More Than a Pleasant Scent: A Review on Essential Oils Supporting the Immune System. Molecules 2019; 24:E4530. [PMID: 31835699 PMCID: PMC6943609 DOI: 10.3390/molecules24244530] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 12/03/2019] [Accepted: 12/07/2019] [Indexed: 12/14/2022] Open
Abstract
The augmenting acceptance and application of herbal medicine in prevention and treatment of diseases also involve the use of plant essential oils (EOs) through different routes of administration (aromatherapy). Scientific data supporting the efficacy of certain herbal products are continuously growing; however, the cumulative evidence is not always sufficient. The anti-inflammatory properties of EOs have been investigated more extensively and also reviewed in different settings, but so far, our review is the first to summarize the immune-supporting properties of EOs. Our aim here is to synthesize the currently available data on the immune function enhancing effects of EOs. An online search was conducted in the PubMed database, which was terminated at the end of July 2019. Other articles were found in the reference lists of the preselected papers. Studies that applied whole EOs with known components, or single EO constituents under in vitro or in vivo laboratory conditions, or in human studies, and de facto measured parameters related to immune function as outcome measures were included. Two specific fields, EO dietary supplementation for livestock and fish, and forest bathing are also explored. Some EOs, particularly eucalyptus and ginger, seem to have immune function enhancing properties in multiple studies.
Collapse
Affiliation(s)
- Agnes Peterfalvi
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
- Neurobiology of Stress Research Group, Szentagothai Research Centre, University of Pecs, Ifjusag utja 20., 7624 Pecs, Hungary
| | - Eva Miko
- Department of Medical Microbiology and Immunology, Medical School, University of Pecs, Szigeti ut 12., 7624 Pecs, Hungary; (E.M.); (L.S.)
| | - Tamas Nagy
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
| | - Barbara Reger
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
| | - Diana Simon
- Department of Immunology and Biotechnology, Medical School, University of Pecs, Szigeti ut 12., 7624 Pecs, Hungary;
| | - Attila Miseta
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
| | - Boldizsár Czéh
- Department of Laboratory Medicine, Medical School, University of Pecs, Ifjusag utja 13., 7624 Pecs, Hungary; (T.N.); (B.R.); (A.M.); (B.C.)
- Neurobiology of Stress Research Group, Szentagothai Research Centre, University of Pecs, Ifjusag utja 20., 7624 Pecs, Hungary
| | - Laszlo Szereday
- Department of Medical Microbiology and Immunology, Medical School, University of Pecs, Szigeti ut 12., 7624 Pecs, Hungary; (E.M.); (L.S.)
| |
Collapse
|
5
|
Effect of Massoia ( Massoia aromatica Becc.) Bark on the Phagocytic Activity of Wistar Rat Macrophages. Sci Pharm 2018; 86:scipharm86020019. [PMID: 29748470 PMCID: PMC6027675 DOI: 10.3390/scipharm86020019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2018] [Revised: 04/28/2018] [Accepted: 05/07/2018] [Indexed: 11/16/2022] Open
Abstract
The essential oil of Massoia (Massoia aromatica Becc., Lauraceae) bark is a potential immunomodulator in vitro. This study evaluated the potential immunomodulatory effects of Massoia bark infusion on the nonspecific immune response (phagocytosis) of Wistar rats. For the in vitro assay, macrophages were treated with the freeze-dried infusion at the concentrations of 2.5, 5, 10, 20, or 40 µg/mL media. For the in vivo assay, two-month-old male Wistar rats were divided into five groups. The baseline group received distilled water at the dose of 1 mL/100 g body weight (BW), with the herbal product containing Phyllanthus niruri extract that was administered as the positive control at the dose of 0.54 mL/rat. The treatment groups received the infusion at a dose of 100, 300, or 500 mg/100 g BW. Treatments were given orally every day for 14 days. The ability of macrophage cells to phagocyte latex was determined as phagocytic index (PI), and it was observed under microscopy with 300 macrophages. The in vitro study revealed that the phagocytic activity of the infusion-treated macrophages significantly increased in comparison with that of the control macrophages in a concentration-dependent manner. Among all of the treatment concentrations, the concentration of 40 µg/mL provided the highest activity with a PI value of 70.51 ± 1.11%. The results of the in vivo assay confirmed those of the in vitro assay. The results of the present study indicate that Massoia bark can increase the phagocytic activity of rat macrophage cells.
Collapse
|
6
|
Rabel F, Sherma J. Review of the state of the art of preparative thin-layer chromatography. J LIQ CHROMATOGR R T 2017. [DOI: 10.1080/10826076.2017.1294081] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Affiliation(s)
- Fred Rabel
- ChromHELP, LLC, Woodbury, New Jersey, USA
| | - Joseph Sherma
- Department of Chemistry, Lafayette College, Easton, Pennsylvania, USA
| |
Collapse
|